logo

Becton, Dickinson And Company (BDX)



Trade BDX now with
  Date
  Headline
5/12/2022 6:52:53 AM BD Launches Fully Automated, High-Throughput Infectious Disease Molecular Diagnostic Platform In The U.S.
5/11/2022 6:52:26 AM Babson, BD Expand Strategic Partnership
5/5/2022 6:35:00 AM Becton, Dickinson and Company (BDX) Has Raised Its FY22 Revenue Estimate To $19.6 - $19.8 Bln From $19.55 - $19.75 Bln
5/5/2022 6:34:24 AM Becton, Dickinson and Company (BDX) Has Raised Its FY22 EPS Estimate To 12.85 - 13.00 From 12.80 - 13.00
5/5/2022 6:31:38 AM BD Q2 GAAP EPS $1.50; Adj EPS $3.18
4/26/2022 4:17:24 PM Becton, Dickinson and Company (BDX) Declares Quarterly Dividend of $ 0.87, Record Date 6/9/2022
4/22/2022 6:51:22 AM BD Announces Formation Of Sustainable Medical Technology Institute
4/1/2022 6:51:46 AM BD Announces Completion Of Embecta Corp. Spinoff
3/30/2022 8:02:13 AM BD Announces Early Tender Results For Cash Tender Offers By Morgan Stanley & Co. LL
2/8/2022 6:52:21 AM BD Says Collaborates With ReturnSafe To Help Employers Manage COVID-19 Testing
2/3/2022 6:36:26 AM Becton, Dickinson and Company (BDX) Has Raised Its FY22 Revenue Estimate To $19.55 - $19.75 Bln From $19.3 - $19.5 Bln
2/3/2022 6:35:55 AM Becton, Dickinson and Company (BDX) Has Raised Its FY22 EPS Estimate To 12.80 - 13.00 From 12.30 - 12.50
2/3/2022 6:32:42 AM BD Q1 GAAP EPS $2.28; Adj EPS $3.64